Back before Covid, it was bumping $100 a share. So it’s fallen a good bit over three years. The only plus I can see...it does pay in the range of 1.5-percent on the dividend. Whether it stays there or not....unknown.
I’ll suggest that it falls down into the mid-40s and someone makes a hostile take-over attempt...to buy 51-percent, and rebrand/rename them.
The dividends won’t hold after the loss in volumes and revenues.
This would then prompt more selling, reducing the stock price.
As to a hostile takeover - two points against that
1. It is a toxic brand name now and owns toxic brand-names. No company wants to be tainted with that
2. Anyone who could afford to buy them would create a monopoly in some markets. This would not be allowed by anti-monopoly regulators.
Bud is supposed to report quarterly earnings on July 27. I expect it will not be as good as same time last year.
https://www.nasdaq.com/market-activity/stocks/bud/earnings
It’s amazing to watch a brand die in less than a year. Hope those ESG points were worth it. They took their mark.....NWO demanded it...